<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163858">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00965003</url>
  </required_header>
  <id_info>
    <org_study_id>ENT0019</org_study_id>
    <secondary_id>96536</secondary_id>
    <secondary_id>SU-05292009-2661</secondary_id>
    <nct_id>NCT00965003</nct_id>
  </id_info>
  <brief_title>MRI Imaging of the Human Larynx</brief_title>
  <official_title>High Resolution MRI in the Evaluation of Laryngeal Neoplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if high resolution MRI can detect early invasion of cartilage by laryngeal
      carcinoma, and to determine if high resolution MRI may be superior to conventional MRI
      imaging or CT imaging to detect cartilage invasion.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Absence of key personnel to conduct study
  </why_stopped>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor stage as determined by histopathology in excised larynges.</measure>
    <time_frame>4 to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimate the precision of HRMRI in terms of cartilage invasion.</measure>
    <time_frame>4 to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Tumor stage as determined by HRMRI.</measure>
    <time_frame>24 to 48 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimate the precision of HRMRI in discriminating between edema and tumor in patients with prior radiotherapy or chemotherapy.</measure>
    <time_frame>4 to 6 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3</enrollment>
  <condition>Laryngeal Neoplasms</condition>
  <condition>Head and Neck Cancers</condition>
  <condition>Larynx Cancer</condition>
  <arm_group>
    <arm_group_label>Scan</arm_group_label>
    <description>High resolution MRI to be performed of subject larynx</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI scan</intervention_name>
    <description>Standard of Care</description>
    <arm_group_label>Scan</arm_group_label>
    <other_name>Magnetic Resonance Imaging</other_name>
    <other_name>nuclear magnetic resonance imaging</other_name>
    <other_name>magnetic resonance tomography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Gadoversetamide</intervention_name>
    <description>0.1 mmol/kg, IV</description>
    <arm_group_label>Scan</arm_group_label>
    <other_name>gadolinium-based MRI contrast agent</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Laryngeal cancer patients at Stanford University
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with benign or malignant neoplasm of the larynx.

          -  Patients who have undergone prior surgery, radiation therapy, or chemotherapy for
             cancer of the laryngopharynx will be eligible to participate.

          -  Patients 18 years of age and older at time of evaluation, male and female, all
             ethnicities.

          -  Ability to understand and the willingness to sign a written informed consent
             document.

        Exclusion Criteria:

          -  Pregnancy

          -  Claustrophobia.

          -  Anatomic parameters which preclude scanning, such as limited range of neck motion, or
             inability to remain flat for at least 15 minutes.

          -  Patients with implanted devices (eg, defibrillator, pacemaker) that are a known
             contraindication to magnetic resonance imaging.

          -  Allergy to gadolinium contrast.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward J. Damrose MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 12, 2013</lastchanged_date>
  <firstreceived_date>August 21, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Laryngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
